Omron Corp
TSE:6645
Omron Corp
TSE:6645
Price:
5 196
JPY
-2.13%
Market Closed
Market Cap:
1T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Omron Corp
5196
-113 (-2.13%)
| 52 Week Range |
4 535
6 980
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Omron Corp
Balance Sheet
Balance Sheet Decomposition
Omron Corp
Omron Corp
| Current Assets | 560.3B |
| Cash & Short-Term Investments | 163.8B |
| Receivables | 143.8B |
| Other Current Assets | 252.7B |
| Non-Current Assets | 823.4B |
| Long-Term Investments | 47.4B |
| PP&E | 192.5B |
| Intangibles | 480.4B |
| Other Non-Current Assets | 103B |
| Current Liabilities | 244.9B |
| Accounts Payable | 72.5B |
| Accrued Liabilities | 55.7B |
| Short-Term Debt | 51.3B |
| Other Current Liabilities | 65.4B |
| Non-Current Liabilities | 335.5B |
| Long-Term Debt | 91.9B |
| Other Non-Current Liabilities | 243.6B |
Balance Sheet
Omron Corp
Omron Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
102 622
|
82 910
|
126 026
|
113 023
|
103 850
|
185 533
|
250 755
|
155 484
|
105 279
|
143 086
|
|
| Cash Equivalents |
102 622
|
82 910
|
126 026
|
113 023
|
103 850
|
185 533
|
250 755
|
155 484
|
105 279
|
143 086
|
|
| Total Receivables |
177 151
|
163 439
|
167 890
|
172 948
|
148 310
|
134 027
|
134 405
|
151 022
|
179 205
|
171 210
|
|
| Accounts Receivables |
177 151
|
163 439
|
167 890
|
172 948
|
148 310
|
134 027
|
134 405
|
151 022
|
179 205
|
171 210
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
116 020
|
107 267
|
109 404
|
129 581
|
120 379
|
104 301
|
103 265
|
141 935
|
173 926
|
174 034
|
|
| Other Current Assets |
38 303
|
35 993
|
32 584
|
21 833
|
87 434
|
23 278
|
26 007
|
34 464
|
28 482
|
59 273
|
|
| Total Current Assets |
434 096
|
389 609
|
435 904
|
437 385
|
459 973
|
447 139
|
514 432
|
482 905
|
486 892
|
547 603
|
|
| PP&E Net |
151 452
|
146 565
|
127 615
|
135 103
|
115 083
|
144 853
|
151 181
|
161 844
|
177 086
|
191 158
|
|
| PP&E Gross |
151 452
|
146 565
|
127 615
|
135 103
|
115 083
|
144 853
|
151 181
|
161 844
|
177 086
|
191 158
|
|
| Accumulated Depreciation |
231 157
|
236 864
|
234 852
|
250 468
|
187 370
|
187 535
|
187 577
|
208 623
|
217 086
|
240 822
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
108 881
|
|
| Goodwill |
0
|
30 253
|
30 385
|
38 705
|
40 532
|
38 568
|
39 160
|
39 718
|
43 125
|
361 783
|
|
| Long-Term Investments |
81 424
|
62 103
|
52 309
|
56 211
|
55 019
|
55 033
|
46 582
|
168 448
|
180 680
|
47 828
|
|
| Other Long-Term Assets |
44 039
|
54 795
|
51 488
|
77 548
|
79 271
|
72 531
|
69 024
|
77 714
|
110 377
|
97 476
|
|
| Other Assets |
0
|
30 253
|
30 385
|
38 705
|
40 532
|
38 568
|
39 160
|
39 718
|
43 125
|
361 783
|
|
| Total Assets |
711 011
N/A
|
683 325
-4%
|
697 701
+2%
|
744 952
+7%
|
749 878
+1%
|
758 124
+1%
|
820 379
+8%
|
930 629
+13%
|
998 160
+7%
|
1 354 729
+36%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
92 702
|
82 606
|
89 362
|
93 792
|
71 360
|
64 496
|
69 561
|
86 827
|
92 855
|
82 548
|
|
| Accrued Liabilities |
45 622
|
44 865
|
46 348
|
50 705
|
41 464
|
50 765
|
59 124
|
65 571
|
72 677
|
67 187
|
|
| Short-Term Debt |
0
|
2
|
156
|
0
|
0
|
0
|
0
|
20 000
|
213
|
22 548
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 451
|
|
| Other Current Liabilities |
38 438
|
35 190
|
36 215
|
38 281
|
62 731
|
36 038
|
32 685
|
39 274
|
44 275
|
52 426
|
|
| Total Current Liabilities |
176 762
|
162 663
|
172 081
|
182 778
|
175 555
|
151 299
|
161 370
|
211 672
|
210 020
|
231 160
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
92 075
|
|
| Deferred Income Tax |
697
|
660
|
763
|
706
|
733
|
1 717
|
1 671
|
2 177
|
2 052
|
16 419
|
|
| Minority Interest |
2 325
|
2 316
|
1 728
|
1 856
|
2 099
|
2 174
|
2 500
|
2 744
|
2 754
|
164 307
|
|
| Other Liabilities |
41 458
|
72 968
|
54 100
|
54 082
|
67 279
|
72 519
|
47 980
|
48 809
|
54 861
|
64 082
|
|
| Total Liabilities |
221 242
N/A
|
238 607
+8%
|
228 672
-4%
|
239 422
+5%
|
245 666
+3%
|
227 709
-7%
|
213 521
-6%
|
265 402
+24%
|
269 687
+2%
|
568 043
+111%
|
|
| Equity | |||||||||||
| Common Stock |
64 100
|
64 100
|
64 100
|
64 100
|
64 100
|
64 100
|
64 100
|
64 100
|
64 100
|
64 100
|
|
| Retained Earnings |
314 577
|
332 365
|
363 813
|
410 890
|
455 465
|
472 749
|
499 116
|
542 069
|
596 536
|
584 162
|
|
| Additional Paid In Capital |
99 070
|
99 101
|
99 138
|
99 588
|
100 233
|
100 521
|
101 403
|
100 652
|
98 506
|
98 997
|
|
| Unrealized Security Profit/Loss |
18 466
|
11 884
|
5 765
|
7 426
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
467
|
644
|
659
|
19 689
|
45 386
|
23 349
|
24 816
|
54 607
|
70 616
|
69 969
|
|
| Other Equity |
9 989
|
62 088
|
63 128
|
56 785
|
70 200
|
83 606
|
32 945
|
13 013
|
39 947
|
109 396
|
|
| Total Equity |
489 769
N/A
|
444 718
-9%
|
469 029
+5%
|
505 530
+8%
|
504 212
0%
|
530 415
+5%
|
606 858
+14%
|
665 227
+10%
|
728 473
+10%
|
786 686
+8%
|
|
| Total Liabilities & Equity |
711 011
N/A
|
683 325
-4%
|
697 701
+2%
|
744 952
+7%
|
749 878
+1%
|
758 124
+1%
|
820 379
+8%
|
930 629
+13%
|
998 160
+7%
|
1 354 729
+36%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
217
|
214
|
214
|
211
|
205
|
202
|
202
|
199
|
197
|
197
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
